Recent Quarter Total Invested
$3.69 B
Recent Quarter Institutional Ownership Percentage
114.08%
Total Invested of Last Quarter
$3.76 B
Ownership Percentage of Last Quarter
111.23%
Crinetics Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| BLACKROCK INC. | 08/13/2024 | 6.23 M | $279.06 M | 14.61% | 8.62% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 08/15/2024 | 6.11 M | $273.76 M | 16.95% | 8.46% |
| WELLINGTON MANAGEMENT GROUP LLP | 08/14/2024 | 4.62 M | $206.95 M | 55.49% | 6.39% |
| VANGUARD GROUP INC | 08/13/2024 | 4.51 M | $202.20 M | 26.28% | 6.25% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 08/14/2024 | 4.41 M | $197.37 M | 15.26% | 6.10% |
| ECOR1 CAPITAL, LLC | 08/14/2024 | 4.16 M | $186.12 M | 0.00% | 5.75% |
| FMR LLC | 08/13/2024 | 4.10 M | $183.50 M | -8.22% | 5.67% |
| STATE STREET CORP | 08/14/2024 | 2.81 M | $125.99 M | -13.59% | 3.89% |
| POINT72 ASSET MANAGEMENT, L.P. | 09/16/2024 | 2.78 M | $124.55 M | -43.82% | 3.85% |
| JENNISON ASSOCIATES LLC | 08/05/2024 | 2.78 M | $124.52 M | -1.34% | 3.85% |
| PARADIGM BIOCAPITAL ADVISORS LP | 08/14/2024 | 2.51 M | $112.57 M | -19.57% | 3.48% |
| JANUS HENDERSON GROUP PLC | 08/14/2024 | 2.46 M | $109.97 M | 24.14% | 3.40% |
| GEODE CAPITAL MANAGEMENT, LLC | 08/09/2024 | 1.68 M | $75.19 M | 19.76% | 2.32% |
| PERCEPTIVE ADVISORS LLC | 08/16/2024 | 1.48 M | $66.12 M | 0.00% | 2.04% |
| CORMORANT ASSET MANAGEMENT, LP | 08/14/2024 | 1.35 M | $60.47 M | 17.39% | 1.87% |
| T. ROWE PRICE INVESTMENT MANAGEMENT, INC. | 08/14/2024 | 1.35 M | $60.34 M | -49.25% | 1.86% |
| ORBIMED ADVISORS LLC | 08/14/2024 | 1.28 M | $57.37 M | -7.52% | 1.77% |
| FIRST LIGHT ASSET MANAGEMENT, LLC | 08/14/2024 | 1.20 M | $53.77 M | -28.97% | 1.66% |
| ARTAL GROUP S.A. | 08/14/2024 | 1.07 M | $47.75 M | -23.33% | 1.47% |
| NOVO HOLDINGS A/S | 08/20/2024 | 1.00 M | $44.79 M | -8.98% | 1.38% |
| LORD, ABBETT & CO. LLC | 10/07/2024 | 887,921 | $39.77 M | -7.95% | 1.23% |
| FRANKLIN RESOURCES INC | 08/14/2024 | 861,422 | $38.58 M | 108.47% | 1.19% |
| MORGAN STANLEY | 10/17/2024 | 838,625 | $37.56 M | 36.99% | 1.16% |
| EVENTIDE ASSET MANAGEMENT, LLC | 08/13/2024 | 735,088 | $32.92 M | -30.63% | 1.02% |
| SCHONFELD STRATEGIC ADVISORS LLC | 08/14/2024 | 653,557 | $29.27 M | 383.07% | 0.90% |
| GOLDMAN SACHS GROUP INC | 08/13/2024 | 649,190 | $29.08 M | -24.87% | 0.90% |
| ENSIGN PEAK ADVISORS, INC | 08/13/2024 | 616,227 | $27.60 M | -0.85% | 0.85% |
| NORTHERN TRUST CORP | 08/14/2024 | 606,037 | $27.14 M | 0.77% | 0.84% |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 08/12/2024 | 597,049 | $26.74 M | 24.77% | 0.83% |
| IKARIAN CAPITAL, LLC | 08/14/2024 | 588,818 | $26.37 M | -8.53% | 0.81% |
| BIOIMPACT CAPITAL LLC | 08/14/2024 | 557,184 | $24.96 M | 15.94% | 0.77% |
| STEMPOINT CAPITAL LP | 08/13/2024 | 551,095 | $24.68 M | -11.08% | 0.76% |
| DIMENSIONAL FUND ADVISORS LP | 08/09/2024 | 546,759 | $24.49 M | -14.68% | 0.76% |
| BNP PARIBAS ASSET MANAGEMENT HOLDING S.A. | 07/30/2024 | 546,234 | $24.47 M | 0.65% | 0.76% |
| AFFINITY ASSET ADVISORS, LLC | 08/14/2024 | 515,000 | $23.07 M | 9.57% | 0.71% |
| FARALLON CAPITAL MANAGEMENT LLC | 08/14/2024 | 497,000 | $22.26 M | 9,840.00% | 0.69% |
| FIERA CAPITAL CORP | 10/31/2024 | 480,409 | $21.52 M | 1.03% | 0.66% |
| SATURN V CAPITAL MANAGEMENT LLC | 08/14/2024 | 479,681 | $21.48 M | -27.34% | 0.66% |
| NUVEEN ASSET MANAGEMENT, LLC | 08/09/2024 | 462,766 | $20.73 M | -16.43% | 0.64% |
| FISHER ASSET MANAGEMENT, LLC | 08/14/2024 | 444,670 | $19.92 M | 1.98% | 0.62% |
| HOOD RIVER CAPITAL MANAGEMENT LLC | 08/14/2024 | 410,342 | $18.38 M | 100.00% | 0.57% |
| INTEGRAL HEALTH ASSET MANAGEMENT, LLC | 08/14/2024 | 400,000 | $17.92 M | 23.08% | 0.55% |
| QUBE RESEARCH & TECHNOLOGIES LTD | 08/14/2024 | 390,941 | $17.51 M | 312.09% | 0.54% |
| BANK OF NEW YORK MELLON CORP | 07/25/2024 | 386,450 | $17.31 M | 30.35% | 0.53% |
| GW&K INVESTMENT MANAGEMENT, LLC | 08/12/2024 | 377,663 | $16.92 M | -2.68% | 0.52% |
| FIRST TURN MANAGEMENT, LLC | 08/08/2024 | 369,302 | $16.54 M | 100.00% | 0.51% |
| LAURION CAPITAL MANAGEMENT LP | 08/14/2024 | 350,766 | $15.71 M | -44.34% | 0.49% |
| WALLEYE CAPITAL LLC | 08/14/2024 | 315,220 | $14.12 M | 30.60% | 0.44% |
| DUQUESNE FAMILY OFFICE LLC | 08/14/2024 | 309,000 | $13.84 M | 0.00% | 0.43% |
| BANK OF AMERICA CORP /DE/ | 08/14/2024 | 305,169 | $13.67 M | -14.55% | 0.42% |
Crinetics Pharmaceuticals, Inc.institutional Ownership - Frequently Asked Questions
-
Who are the largest shareholders of CRNX shares?
During the previous two years, 227 institutional investors and hedge funds held shares of Crinetics Pharmaceuticals, Inc.. The most heavily invested institutionals were:
MASSMUTUAL TRUST CO FSB/ADV: 0
Householder Group Estate & Retirement Specialist, LLC: 0
FARMERS & MERCHANTS INVESTMENTS INC: 0
INNEALTA CAPITAL, LLC: 0
Entropy Technologies, LP: 0
BlackRock Inc.: 6.23 M
-
What percentage of Crinetics Pharmaceuticals, Inc. stock is owned by institutional investors?
114.08% of Crinetics Pharmaceuticals, Inc. stock is owned by institutional investors.
-
How much institutional buying is happening at CRNX ?
Institutional investors have bought a total of 80.63 M shares in the last 24 months. This purchase volume represents approximately $4.67 B in transactions.